Negative Prognostic Impact Of High CD33 Expression Is Negated With The Use Of Gemtuzumab Ozogamicin: A Report From The Children’s Oncology Group
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Richard Aplenc |
| Publication date | November 15, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |